Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises
Wen Li(Roswell Park Comprehensive Cancer Center), Dean G. Tang(Roswell Park Comprehensive Cancer Center)
Cited by 31
Related Papers
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
|Nature Medicine|2011|1.4k
Understanding cancer stem cell heterogeneity and plasticity
|Cell Research|2012|572
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer
|Nature Communications|2016|238
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
|Journal of Hematology & Oncology|2025|128